| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vaxcyte, Inc. (PCVX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. PCVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 496.9K | $25.90M | - | |
| COO | 160.7K | $8.38M | - | |
| CFO | 104.4K | $5.44M | - | |
| Other | 76.0K | $3.96M | - | |
| VP | 29.0K | $1.51M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 | Pickering Grant50 | Chief Executive Officer | Sale+OE | 22,000 | $24.82 | $546,142.53 | -1.0% | -19.4% | +46.8% | |
| Mar 18, 2022 | Guggenhime Andrew46 | President And CFO | Sale+OE | 3,100 | $26.13 | $80,992.77 | -7.1% | -27.9% | +44.6% | |
| Mar 11, 2022 | Fairman Jeff | VP, Research | Sell | 10,000 | $25.50 | $255,000.00 | -2.9% | -21.7% | +55.7% | |
| Mar 10, 2022 | Sauer Paul | SVP Process Dev, Manufacturing | Sell | 6,000 | $25.00 | $150,000.00 | -16.2% | -17.1% | +51.7% | |
| Mar 1, 2022 | Guggenhime Andrew46 | President And CFO | Sale+OE | 6,200 | $24.00 | $148,800.00 | -66.5% | +0.6% | +74.8% | |
| Feb 24, 2022 | Wassil Jim53 | Chief Operating Officer | Sale+OE | 10,000 | $22.00 | $220,000.00 | -35.8% | +13.4% | +84.5% | |
| Dec 29, 2021 | Sauer Paul | SVP Process Dev, Manufacturing | Sell | 6,000 | $25.00 | $150,000.00 | -18.1% | +2.9% | +97.3% | |
| Dec 27, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,750 | $23.60 | $112,092.50 | -27.5% | +2.0% | +96.7% | |
| Dec 23, 2021 | Guggenhime Andrew46 | President And CFO | Sale+OE | 3,100 | $24.00 | $74,400.00 | -49.8% | +0.5% | +93.2% | |
| Dec 16, 2021 | Fairman Jeff | VP, Research | Sale+OE | 4,619 | $22.50 | $103,927.50 | -42.9% | +23.8% | +115.8% |